BBWI interim CFO granted 10,309 restricted shares

Javitch Tom reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Javitch Tom reported acquisition or exercise transactions in this Form 4 filing.

Bath & Body Works, Inc. reported that Interim CFO Tom Javitch received a grant of 10,309 shares of common stock on June 12, 2026 as a compensation award. The restricted stock units vest 100% on the one year anniversary of June 12, 2026. Following this grant, Javitch directly holds 59,003 common shares.

Insider Trade Summary

Grant/Award: 10,309 shares

Grant/Award 1 txn

Insider Javitch Tom

Role Interim CFO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $0.50 par value	10,309	$0.00	$0.00

Holdings After Transaction: Common Stock, $0.50 par value — 59,003 shares (Direct)

Footnotes (1)

1. F1. One-time grant of restricted stock units vesting 100% on the one year anniversary of June 12, 2026.

Key Figures

Equity grant size: 10,309 shares Grant price per share: $0.00 per share Shares held after grant: 59,003 shares +2 more

5 metrics

Equity grant size 10,309 shares Restricted stock unit grant on June 12, 2026

Grant price per share $0.00 per share Compensation award, not open-market purchase

Shares held after grant 59,003 shares Total direct common stock holdings after transaction

Vesting terms 100% after one year Vests on the one year anniversary of June 12, 2026

Transaction code A Grant, award, or other acquisition of common stock

Key Terms

restricted stock units, grant, award, or other acquisition, Form 4

3 terms

restricted stock units financial

"One-time grant of restricted stock units vesting 100% on the one year anniversary of June 12, 2026."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

grant, award, or other acquisition financial

"Transaction code A is described as Grant, award, or other acquisition."

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Bath & Body Works (BBWI) Interim CFO Tom Javitch report in this Form 4?

Interim CFO Tom Javitch reported receiving a grant of 10,309 shares of Bath & Body Works common stock. The award was granted at $0.00 per share as part of his compensation and increased his direct holdings to 59,003 shares.

Was the BBWI insider transaction by Tom Javitch an open-market purchase or a grant?

The transaction was a grant/award acquisition, not an open-market purchase. The Form 4 uses transaction code A, indicating a grant or award received as compensation with a price of $0.00 per share rather than a market trade.

How many Bath & Body Works (BBWI) shares does Tom Javitch hold after this grant?

After the grant, Interim CFO Tom Javitch directly holds 59,003 shares of Bath & Body Works common stock. This figure reflects his total direct ownership immediately following the 10,309-share restricted stock unit award reported in the Form 4.

What is the vesting schedule for Tom Javitch’s BBWI restricted stock units?

The award is described as a one-time grant of restricted stock units that will vest 100% on the one year anniversary of June 12, 2026. This means all units from this grant vest together on that single future date.

Does the Form 4 for BBWI’s Tom Javitch involve any derivative securities or option exercises?

No derivative securities or option exercises are reported in this Form 4. The filing lists only a non-derivative grant of common stock and shows an empty derivative summary, indicating no option or other derivative transactions in this report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/15/2026 - 04:20 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Javitch Tom

(Last) (First) (Middle)

THREE LIMITED PARKWAY

(Street)

COLUMBUS OHIO 43230

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bath & Body Works, Inc. [ BBWI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Interim CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.50 par value	06/12/2026		A		10,309(1)	A	$0.0000	59,003	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. One-time grant of restricted stock units vesting 100% on the one year anniversary of June 12, 2026.

	Robert J. Tannous, Attorney-in-Fact	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)